HelicoVax

N/A

Report date: 2025/01/26 19:20:32

Base Information

Drug NameHelicoVax

Drug Alias NameT cell epitope-based prophylactic vaccine (EpiVax)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHelicobacter pylori infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEpiVax Inc

China Registration ClassN/A

Develop Information

Active CompaniesEpiVax Inc

Inactive CompaniesN/A

Active IndicationsHelicobacter pylori infection

Inactive IndicationsN/A

Other Information

ATC CodeN/A